Risks of clinical approbation protocols for medical technologies: classification and assessment based on obstetric and gynecological protocols
Bulletin of maternal and child care · 30.07.2026 · 3 (2) · 10-19
DOI: 10.69964/bmcc-2026-3-2-10-19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of maternal and child care, online erschienen am 30.07.2026. Verfasst von G. N. Chistyakova und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Clinical approbation is one of the mechanisms for introducing new medical technologies into practical healthcare, including them in clinical guidelines and, subsequently, in the public financing system.
Objective
To identify and classify the risks inherent in clinical approbation protocols and to propose a tool for their assessment at the protocol preparation stage. Materials and Methods. A descriptive, analytical, and content analysis study was conducted. Three 2022 obstetric and gynecological protocols from the register of implemented protocols of the Russian Ministry of Health (2015–2026) were reviewed. Risks were grouped into eight areas, and a risk diagram and a weighted summary risk index (0–30) were constructed for each protocol.
Results
Methodological, documentary, safety, organizational, technological, economic, translational, and legal risks were identified. According to the developed index (0–30), the radiofrequency protocol (19) has a higher risk due to documentation discrepancies and technological dependence. The indices for the rehabilitation and surgical protocols were 16 and 11, respectively. All three protocols were classified as moderate risk. Technological dependence and the risk of overstating conclusions were common to all protocols. A risk mitigation checklist for each area is proposed.
Conclusion
The clinical trial protocol is a source of manageable implementation risks, a significant portion of which are identified at the document level before the results are obtained. The scoring and checklist allow for the early identification of protocol vulnerabilities. Protocol readiness is not the same as implementation: only 13.81% of tested methods are included in clinical guidelines, on average after 2–3 years.
Zitieren
APA
Chistyakova, G. N., Semenov, Y. A., Melkozerova, O. A., & Mikhelson, A. A. (2026). Risks of clinical approbation protocols for medical technologies: classification and assessment based on obstetric and gynecological protocols. Bulletin of maternal and child care, 3(2), 10-19. https://doi.org/10.69964/bmcc-2026-3-2-10-19
Vancouver
Chistyakova GN, Semenov YA, Melkozerova OA, Mikhelson AA. Risks of clinical approbation protocols for medical technologies: classification and assessment based on obstetric and gynecological protocols. Bulletin of maternal and child care. 2026;3(2):10-19. doi:10.69964/bmcc-2026-3-2-10-19
BibTeX
@article{Chistyakova2026,
author = {Chistyakova, G. N. and Semenov, Yu. A. and Melkozerova, O. A. and Mikhelson, A. A.},
title = {Risks of clinical approbation protocols for medical technologies: classification and assessment based on obstetric and gynecological protocols},
journal = {Bulletin of maternal and child care},
year = {2026},
volume = {3},
number = {2},
pages = {10--19},
doi = {10.69964/bmcc-2026-3-2-10-19}
}
EUVIMED